An open-label, single-group, multicenter Phase II study testing DCVAC/OvCa in combination with standard of care chemotherapy for patients with ovarian cancer after first relapse
Phase of Trial: Phase II
Latest Information Update: 01 Dec 2017
At a glance
- Drugs DCVAC OvCa (Primary)
- Indications Ovarian cancer
- Focus Therapeutic Use
- Sponsors SOTIO
- 01 Dec 2017 New trial record
- 28 Nov 2017 This trial is conducted in collaboration with CEEGOG (Central and Eastern European Gynecological Oncology Group), as reported in a SOTIO media release.
- 28 Nov 2017 According to a SOTIO media release, first patient has been enrolled t the General University Hospital in Prague at the department of Professor David Cibula in this trial.